Skip to main content
Journal cover image

Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy

Publication ,  Conference
Roe, MT; Szarek, M; Li, QH; Bhatt, DL; Bittner, V; Goodman, SG; Harrington, RA; Lopez-Jaramillo, P; Lopes, RD; Louie, MJ; Moriarty, PM ...
Published in: EUROPEAN HEART JOURNAL
October 1, 2019

Duke Scholars

Published In

EUROPEAN HEART JOURNAL

EISSN

1522-9645

ISSN

0195-668X

Publication Date

October 1, 2019

Volume

40

Start / End Page

2474 / 2474

Location

Paris, FRANCE

Publisher

OXFORD UNIV PRESS

Conference Name

Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Roe, M. T., Szarek, M., Li, Q. H., Bhatt, D. L., Bittner, V., Goodman, S. G., … Schwartz, G. G. (2019). Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy. In EUROPEAN HEART JOURNAL (Vol. 40, pp. 2474–2474). Paris, FRANCE: OXFORD UNIV PRESS.
Roe, M. T., M. Szarek, Q. H. Li, D. L. Bhatt, V. Bittner, S. G. Goodman, R. A. Harrington, et al. “Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy.” In EUROPEAN HEART JOURNAL, 40:2474–2474. OXFORD UNIV PRESS, 2019.
Roe MT, Szarek M, Li QH, Bhatt DL, Bittner V, Goodman SG, et al. Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2019. p. 2474–2474.
Roe, M. T., et al. “Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy.” EUROPEAN HEART JOURNAL, vol. 40, OXFORD UNIV PRESS, 2019, pp. 2474–2474.
Roe MT, Szarek M, Li QH, Bhatt DL, Bittner V, Goodman SG, Harrington RA, Lopez-Jaramillo P, Lopes RD, Louie MJ, Moriarty PM, Vogel RA, Baccara-Dinet MT, Steg PG, Schwartz GG. Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2019. p. 2474–2474.
Journal cover image

Published In

EUROPEAN HEART JOURNAL

EISSN

1522-9645

ISSN

0195-668X

Publication Date

October 1, 2019

Volume

40

Start / End Page

2474 / 2474

Location

Paris, FRANCE

Publisher

OXFORD UNIV PRESS

Conference Name

Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology